Amby Medical Services Ltd 14617076 false 2023-01-25 2024-01-31 2024-01-31 The principal activity of the company is locum services Digita Accounts Production Advanced 6.30.9574.0 true 14617076 2023-01-25 2024-01-31 14617076 2024-01-31 14617076 core:CurrentFinancialInstruments core:WithinOneYear 2024-01-31 14617076 bus:Micro-entities 2023-01-25 2024-01-31 14617076 bus:AuditExemptWithAccountantsReport 2023-01-25 2024-01-31 14617076 bus:FilletedAccounts 2023-01-25 2024-01-31 14617076 bus:SmallCompaniesRegimeForAccounts 2023-01-25 2024-01-31 14617076 bus:RegisteredOffice 2023-01-25 2024-01-31 14617076 bus:Director1 2023-01-25 2024-01-31 14617076 bus:PrivateLimitedCompanyLtd 2023-01-25 2024-01-31 14617076 countries:EnglandWales 2023-01-25 2024-01-31 iso4217:GBP xbrli:pure

Registration number: 14617076

Amby Medical Services Ltd

Unaudited Filleted Financial Statements

for the Period from 25 January 2023 to 31 January 2024

 

Amby Medical Services Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

2

 

Amby Medical Services Ltd

Company Information

Director

Dr B Agoe

Registered office

75 Tower Gardens
Tottenham
London
N17 7PN

 

Amby Medical Services Ltd

(Registration number: 14617076)
Balance Sheet as at 31 January 2024

2024
£

Fixed Assets

1,650

Current assets

16,437

Creditors: Amounts falling due within one year

(15,913)

Net current assets

524

 

2,174

Capital and reserves

2,174

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
75 Tower Gardens
Tottenham
London
N17 7PN

These financial statements were authorised for issue by the director on 23 October 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1.

For the financial period ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 23 October 2024
 

.........................................
Dr B Agoe
Director